Open original FDA record ↗Recall record
- FDA identifier
- Z-0217-2007
- Company in FDA record
- Biogenex Laboratories
- FDA classification date
- Dec 8, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Mislabeling: The product's "contents section " labeling (outer box) is mislabeled incorrectly printed as '1 x 100 mL Alk Phos Label' which should read '1 x 100 mL HRP Label'. A second, smaller label, incorrectly reads "RTU MultiLink HPR/AEC" which should be labeled as "RTU MultiLink HPR". The reagent vials in the box are correctly labeled.
Source facts
- Action
- The firms provided written notificaiton letter on approximately 10/03/06, which includes a ''reply back form'' which the firm has requested to be sent back to them. The firm has asked distributors to inform their accounts of the correction, in the event that the product has been shipped out to customers.
- Initiated
- 2006-10-03
- Root cause
- Other
- Terminated
- 2007-12-04
- Distribution
- Worldwide-USA (including VA Medical Center) and Greece, Jordan, France, India, Taiwan, United Kingdom, Turkey, and Italy
- Recall number
- Z-0217-2007
- Recall status
- Terminated
- CDRH record ID
- 48784
- FDA classified
- 2006-12-08
- Recall event number
- 36514